5
Table 2. Screening for Comorbidities of Pediatric
Overweight or Obesity
Comorbidity
Tests and Interpretation
(To convert mg/dL to mmol/L, multiply by 0.0555 for glucose,
0.0259 for cholesterol, and 0.0113 for triglycerides.)
Prediabetes
HbA1c
IFG (verify fasting
status)
IGT (if OGTT
is used)
• 5.7% to <6.5% (39 – <48 mmol/mol) (note the
unpredictability of this test in pediatrics in the full text
Guideline)
a
• Fasting plasma glucose of ≥100 but <126 mg/dL
(≥5.6 but <7.0 mmol/L)
• Two-hour glucose of ≥140 but <200 mg/dL
(≥7.8 but <11.1 mmol/L)
Diabetes mellitus
• HbA1c ≥6.5% (≥48 mmol/mol)
a,b
• Fasting plasma glucose of ≥126 mg/dL (≥7.0 mmol/L)
b
• Two-hour plasma glucose of ≥200 mg/dL (≥11.1 mmol/L)
during an OGTT
b
• In a patient with classic symptoms of hyperglycemia, a random
plasma glucose of ≥200 mg/dL
Dyslipidemia Fasting lipids
• Triglycerides (mg/dL): 0–9 y <75 (acceptable), 75–99
(borderline high), ≥100 (high); 10–19 y <90 (acceptable),
90–129 (borderline high), ≥130 (high)
• LDL cholesterol (mg/dL): <110 (acceptable), 110–129
(borderline high), ≥130 (high)
• Total cholesterol (mg/dL): <170 (acceptable), 170–199
(borderline high), ≥200 (high)
• HDL cholesterol (mg/dL): <40 (low), 40–45 (borderline low),
>45 (acceptable)
• Non–HDL cholesterol (mg/dL) (can be nonfasting ) <120
(acceptable), 120–144 (borderline high), ≥145 (high)
